• 25-Hydroxycholesterol–Lysosomal AMPK Axis Reprograms Tumor M

  2026-07-28

  Xiao et al. (2024) reveal how lysosomal 25-hydroxycholesterol activates AMPKα, leading to STAT6-dependent immunosuppressive programming in tumor-associated macrophages. These findings highlight CH25H as a crucial immunometabolic checkpoint, suggesting new strategies to remodel the tumor microenvironment and improve immunotherapy efficacy.

• IWP-L6: Precision Porcupine Inhibitor for Wnt Pathway Assays

  2026-07-28

  IWP-L6 empowers researchers to dissect and modulate Wnt signaling with unmatched precision, enabling breakthroughs in developmental biology and metabolic research. Its sub-nanomolar Porcupine inhibition redefines workflow reproducibility, particularly in branching morphogenesis and zebrafish regeneration assays.

• Masitinib (AB1010): Technical Use in KIT/PDGFR Research

  2026-07-27

  Masitinib (AB1010) is a selective tyrosine kinase inhibitor for research applications where precise inhibition of KIT, PDGFRα, and PDGFRβ is required, such as in cancer biology, mastocytosis, and inflammation studies. It is not suitable for protocols demanding broad-spectrum kinase inhibition or compatibility with aqueous or ethanol-based solvents.

• VX-702: Selective p38α MAPK Inhibition and Phosphatase Targe

  2026-07-27

  Explore how VX-702, a potent p38α MAPK inhibitor, uniquely exploits kinase conformation to enhance research on cytokine regulation and inflammation. This article uncovers new mechanistic insights with practical guidance distinct from standard approaches.

• Dissecting Drug Response Metrics: New In Vitro Cancer Models

  2026-07-26

  Schwartz's dissertation rigorously distinguishes between relative and fractional viability as in vitro drug response metrics, revealing their distinct roles in assessing proliferation arrest versus cell death. These findings inform more nuanced experimental design and data interpretation in cancer pharmacology.

• Ziprasidone HCl: Translational Workflows from Bench to Oncol

  2026-07-25

  Ziprasidone Hydrochloride is redefining translational research through its dual-action as a serotonin-dopamine receptor antagonist and GOT1 inhibitor, supporting both neuroscience and cancer metabolism studies. This article delivers actionable protocols, troubleshooting guidance, and a critical synthesis of recent clinical and preclinical findings to help researchers maximize the utility of Ziprasidone HCl from APExBIO.

• RIPA Lysis Buffer Strong: Optimizing Protein Extraction in B

  2026-07-24

  Harness the robust detergent action of RIPA Lysis Buffer (Strong, without inhibitors) for high-yield protein extraction from challenging tissues like brown adipose tissue (BAT). Discover workflow enhancements, troubleshooting insights, and best practices tailored for metabolic and immunological assays in obesity research.

• Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO): Pract

  2026-07-24

  The Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO) prevents proteolytic degradation during protein extraction, especially in workflows requiring divalent cation compatibility such as phosphorylation analysis. It is not suitable for workflows where EDTA-mediated metalloprotease inhibition is essential or where DMSO sensitivity is a concern.

• 2X Taq PCR Master Mix: Streamlining Genotyping and TA Clonin

  2026-07-23

  Accelerate molecular workflows with the 2X Taq PCR Master Mix (with dye) from APExBIO—engineered for robust DNA amplification, seamless direct gel loading, and superior compatibility with TA cloning. Learn how its ready-to-use formulation and built-in dye reduce errors, enhance reproducibility, and empower translational research.

• Intestinal TM6SF2 Deficiency Drives MASH via the Gut–Liver A

  2026-07-23

  This study identifies intestinal TM6SF2 as a critical protector against metabolic dysfunction-associated steatohepatitis (MASH), linking its deficiency to gut barrier impairment, microbial dysbiosis, and hepatic inflammation. By dissecting the mechanistic role of lipid signaling via the gut–liver axis, the research opens new experimental avenues for targeting metabolic liver disease.

• 2X Taq PCR Master Mix: Applied Workflows for Genotyping & Cl

  2026-07-22

  Leverage the 2X Taq PCR Master Mix (with dye) for streamlined genotyping, direct-to-gel analysis, and TA cloning. This article bridges experimental virology with practical PCR optimization, distilling troubleshooting insights and real-world protocol enhancements.

• URB597 (KDS-4103): Unleashing FAAH Inhibition in Translation

  2026-07-22

  Explore how URB597 (KDS-4103), a potent and selective FAAH inhibitor, is redefining translational pain research by enabling precise endocannabinoid modulation. This article bridges mechanistic insights with actionable guidance, contextualizing APExBIO's URB597 against evolving neuroinflammation and orofacial pain paradigms, and highlighting where this tool uniquely advances the field beyond conventional product pages.

• IGF2BP3–FZD1/7 Axis Drives Stemness and Platinum Resistance

  2026-07-21

  This study identifies IGF2BP3 as a key m6A reader stabilizing FZD1/7 mRNAs, which enhances cancer stem-like properties and carboplatin resistance in triple-negative breast cancer (TNBC). Targeting this axis, either genetically or pharmacologically, represents a promising strategy to sensitize TNBC cells to chemotherapy and potentially improve clinical outcomes.

• DAPT (GSI-IX): Optimizing Notch Pathway Studies in Applied R

  2026-07-21

  DAPT (GSI-IX) is redefining the precision available to researchers dissecting Notch signaling, amyloid processing, and cell fate determination. This guide details actionable protocols, troubleshooting strategies, and translational insights for maximizing assay reliability and biological relevance in neurodegeneration and beyond.

• 2,5-di-tert-butylbenzene-1,4-diol: Advancing SERCA Inhibitio

  2026-07-20

  2,5-di-tert-butylbenzene-1,4-diol (BHQ) is redefining calcium signaling research and stem cell mobilization through selective SERCA inhibition. Discover workflow-optimized strategies and troubleshooting insights that translate cutting-edge findings into robust, reproducible experimental outcomes.

14558 records 1/971 page Next 12345 下5页 Last page